Nipro looks to cost benefits and new markets as it sets up pharma shop in Vietnam
This article was originally published in Scrip
Executive Summary
The pharmaceutical division of Nipro Corp has confirmed to Scrip that it is to make an initial investment of ¥6 billion ($78 million) in a new facility for the production of generic drugs in Vietnam.